Zenith debt restructuring
Agreement reached with five banks to convert $25 mil. of short-term obligations to long-term debt ("The Pink Sheet" Aug. 17, p. 10). Zenith will make principal payments totaling $2.75 mil. through June 1988, with the balance due on Sept. 20, 1989. Interest is payable monthly at an initial rate of one point over prime, increasing to three points "if certain refinancings or assets sales are not effected by April 30, 1988".
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.